Ardent Health Partners (NYSE:ARDT) Price Target Raised to $25.00 at Leerink Partners

Ardent Health Partners (NYSE:ARDT) had its price objective lifted by Leerink Partners from $23.00 to $25.00 in a report released on Tuesday morning,Benzinga reports. They currently have an outperform rating on the stock.

Several other equities analysts have also recently issued reports on the stock. Citigroup began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a “buy” rating and a $21.00 target price on the stock. Royal Bank of Canada began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set an “outperform” rating and a $23.00 target price on the stock. Truist Financial began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a “buy” rating and a $21.00 target price on the stock. Mizuho began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set an “outperform” rating and a $20.00 target price on the stock. Finally, Leerink Partnrs upgraded shares of Ardent Health Partners to a “strong-buy” rating in a research note on Monday, August 12th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $21.82.

Ardent Health Partners Stock Performance

Shares of ARDT stock opened at $17.17 on Tuesday. Ardent Health Partners has a 12 month low of $14.57 and a 12 month high of $20.72. The company has a current ratio of 1.65, a quick ratio of 1.54 and a debt-to-equity ratio of 0.93. The firm’s fifty day simple moving average is $18.32.

Ardent Health Partners (NYSE:ARDT) last announced its earnings results on Wednesday, August 14th. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.05. The business had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.46 billion. As a group, research analysts expect that Ardent Health Partners will post 1.28 earnings per share for the current year.

Institutional Investors Weigh In On Ardent Health Partners

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC bought a new stake in Ardent Health Partners during the 3rd quarter worth approximately $13,119,000. Seven Grand Managers LLC bought a new stake in Ardent Health Partners during the 3rd quarter worth approximately $2,298,000. Charles Schwab Investment Management Inc. bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $526,000. Finally, Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $50,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.